ArticleCancer gene therapy2022

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.

Raoud Marayati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.